RvD1binding with FPR2 attenuates inflammation via Rac1/NOX2 pathway after neonatal hypoxic-ischemic injury in rats

Neuroinflammation plays a crucial role in the pathological development after neonatal hypoxia-ischemia (HI). Resolvin D1 (RvD1), an agonist of formyl peptide receptor 2 (FPR2), has been shown to exert anti-inflammatory effects in many diseases. The objective of this study was to explore the protecti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Exp Neurol
Päätekijät: Liu, Wei, Huang, Juan, Doycheva, Desislava, Gamdzyk, Marcin, Tang, Jiping, Zhang, John H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6708447/
https://ncbi.nlm.nih.gov/pubmed/31247196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2019.112982
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia